16 March 2007
Hepatocyte transplantation-biology and application
M. Gewartowska, Waldemar L. OlszewskiAnn Transplant 2007; 12(1): 27-36 :: ID: 495874
Abstract
Transplantation of liver has been remarkably effective in the treatment of liver failure and liver-based inherited metabolic diseases and has revolutionized the care of patients with end-stage liver disease. Unfortunately demand for transplantable livers is progressively outpacing the supply of donated cadaver organs, resulting in longer waiting times and increased mortality for prospective transplant recipients. Hepatocyte transplantation has been proposed as a method to support patients with liver insufficiency. The current knowledge on this method has been review in this article. Now the two-step collagenase perfusion technique is widely used for isolation of hepatocytes. Liver has been considered as an optimal site for hepatocyte transplantation, however, even in this organ the survival rate of transplanted hepatocytes in extremely low. The main obstacle for wider usage of hepatocyte transplantation is their rapid elimination by recipient macrophages. We tried in animal experiments to downregulate the innate process of recipient cellular attack on implanted hepatocytes by irradiation of recipient and elimination of NK cells. Ligation of bile duct and partial hepatectomies facilitated proliferation of accepted donor hepatocytes and formation of bile canaliculi. The described method is now adjusted to clinical conditions.
Keywords: hepatocyte transplantation, Liver failure, donor shortage
In Press
08 Mar 2024 : Original article
Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...Ann Transplant In Press; DOI: 10.12659/AOT.943532
14 Mar 2024 : Original article
Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort StudyAnn Transplant In Press; DOI: 10.12659/AOT.943652
14 Mar 2024 : Case report
Treatment of Cavernous Transformation of Portal Vein Caused by Hepatic Cystic Echinococcosis Using Ex Vivo ...Ann Transplant In Press; DOI: 10.12659/AOT.942358
15 Mar 2024 : Review article
Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...Ann Transplant In Press; DOI: 10.12659/AOT.941185
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860